Tag: COVID-19

Report: Hospital margins declined during pandemic, not yet recovered

Editor's Note Hospital margins are off to a rough start this year, reports Becker’s Hospital Review March 30. According to a March 28 report by Kaufman Hall, the “median operating margin for hospitals and health systems” was down by 11.8% compared to February 2021 and by 42.4% compared to February…

Read More

By: Tarsilla Moura
March 31, 2022
Share

Protection against COVID-19 after vaccination, previous infection

Editor's Note This study from the UK finds that two doses of the Pfizer-BioNTech vaccine were associated with high short-term protection, but this protection waned considerably after 6 months; whereas, infection-acquired immunity boosted with vaccination remained high more than 1 year after COVID-19 infection. Of 35,768 participants analyzed, 9,488 (27%)…

Read More

By: Judy Mathias
March 31, 2022
Share

Risk factors for COVID-19 in HCWs

Editor's Note This French study finds that contact with COVID-19 patients was not the highest risk of COVID-19 in healthcare workers (HCWs). Of 3,234 HCWs enrolled in the study, 120 (3.8%) contracted COVID-19. The highest risk factors were contact with relatives or other HCWs  with COVID-19. Multivariate analysis showed that…

Read More

By: Judy Mathias
March 31, 2022
Share

Study links COVID-19 to greater diabetes risk

Editor's Note This cohort study by researchers at the VA Saint Louis Health Care System and Saint Louis University finds that after the first 30 days of infection, COVID-19 patients have increased risks and burdens of incident diabetes and antihyperglycaemic use. A total of 181,280 COVID-19 patients in the US…

Read More

By: Judy Mathias
March 30, 2022
Share

NIOSH rescinds approval for Pacific PPE N95 respirator masks

Editor's Note The National Institute for Occupational Safety and Health (NIOSH) announced on March 28 that it had honored a request by Pacific PPE Corp to rescind all of its N95 respirator mask approvals, effective immediately. Respirators with NIOSH approval numbers TC-84A-9278, TC-84A-9299, and TC-84A-9313 will no longer be manufactured,…

Read More

By: Judy Mathias
March 30, 2022
Share

FDA: Class I recall of certain Celltrion USA COVID-19 test kits labeled for research use only

Editor's Note The Food and Drug Administration (FDA), on March 23, identified the recall by Celltrion USA of certain point of care DiaTrust COVID-19 Ag Rapid Test kits (labeled for research use only) as Class I, the most serious. The recall was initiated because the kits were distributed to customers…

Read More

By: Judy Mathias
March 29, 2022
Share

Racial disparities in COVID-19 outcomes of cancer patients

Editor's Note This multi-center study by cancer centers across the US finds that having cancer and COVID-19 is associated with worse outcomes in Black patients compared with White patients. Of 3,506 patients included in the analysis, 1,068 (30%) were Black and 2,438 (70%) were White. At the time of COVID-19…

Read More

By: Judy Mathias
March 28, 2022
Share

Impact of supply chain crisis on surgical services

What happens when global supply chains—which are already typically operated lean across the board—are hit with a once-in-a-century pandemic? An ongoing, collective lesson in economics. The problem is not hard to understand: COVID-19 shutdowns brought manufacturing to a near standstill, during which time the demand for goods increased, and now there…

Read More

By: Carisa Brewster
March 25, 2022
Share

WHO: Takeaways on how 19 countries maintained health services during COVID-19

Editor's Note A December 2021 World Health Organization (WHO) report examines how 19 countries mitigated COVID-19’s effects on providing maternal; newborn; child and adolescent; and aging health services, JAMA Network March 15 reports. The WHO data comes from an initiative lasting from May 2020 to February 2021, during which groups…

Read More

By: Tarsilla Moura
March 25, 2022
Share

NIH begins clinical trial of three mRNA vaccines for HIV

Editor's Note According to a March 14 news release from the National Institutes of Health (NIH), NIH’s National Institute of Allergy and Infectious Diseases (NIAID) launched a Phase 1 clinical trial evaluating three experimental HIV vaccines using the messenger RNA (mRNA) technology. The mRNA technology being tested is the same…

Read More

By: Tarsilla Moura
March 25, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat